NCT05656274View on ClinicalTrials.gov

A Study of the Safety,Tolerability,and Pharmacokinetics of Multiple-Ascending Dose JS1-1-01 in Healty Subjects.

PHASE1CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

November 29, 2022

Primary Completion Date

July 24, 2023

Study Completion Date

July 24, 2023

Conditions

Healthy Volunteers

Interventions

DRUG

JS1-1-01

Oral tables

DRUG

Placebo

Oral tables

Trial Locations (1)

Unknown

Shanghai Mental Health Center, Shanghai

All Listed Sponsors

lead

Tasly Pharmaceutical Group Co., Ltd

INDUSTRY